CClinicalTrials.gg
CompletedNCT05830331ERASSUpdated Apr 26, 2023

Enhanced Recovery After Spine Surgery Randomized Clinical Trial

An interventional study of ERASS Pathway in ERAS, sponsored by University of Pennsylvania. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-04-26.

Sponsored by University of Pennsylvania · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 4 years after the study started (first participant enrolled Feb 2019, registered Mar 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
284
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to compare two different approaches to the care patients receive before, during and after their spinal surgery and to determine if either approach has a significant difference in patient outcomes, opioid use, and recovery following spine surgery. The study will compare the standard-of-care surgical approach taken at the Hospital of the University of Pennsylvania with the Enhanced Recovery After Spine Surgery (ERASS) pathway. ERASS is a program that will provide additional education before your surgery, reduce your opioid consumption, and provide earlier physical therapy than you would normally receive under the standard-of-care approach, among other protocols outlined in this consent. Patients will be randomized to receive either of these approaches and the researchers will collect information to better understand if the ERASS approach provides more patient benefits.

02

Conditions studied

  • ERAS
03

In context

Lead sponsor

University of Pennsylvania is the lead sponsor of 1,635 studies on the registry; 239 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 104 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients 18 and older (both male and female), who present to the department of neurosurgery at the Hospital of the University of Pennsylvania and who are determined to require elective spine surgery with one of two senior spine neurosurgeons, Drs. Malhotra and Marcotte.

Exclusion criteria

Exclusion Criteria:

  • Patients who are pregnant
  • Incarceration
  • Patients under the age of 18
  • Patients unable to participate in the consent procedure
  • Patients undergoing emergent surgery
  • Patients with liver disease
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
284 participants (actual)

Study arms

  • No intervention
    Control
  • Experimental
    Treatment

    Other: ERASS Pathway

Interventions

  • OtherERASS Pathway

    Enhanced Recovery After Spinal Surgery

06

What researchers measure

Primary outcomes

  1. Opioid use during hospitalization

    Total opioid use during hospitalization after surgery

    Time frame: post-operative days during hospital admission, up to 20 days

  2. Opioid use after surgery

    Proportion of patients using opioids one month after surgery

    Time frame: up to one month after surgery

Secondary outcomes

  1. Total Opioid Consumption During Hospitalization Using Morphine Equivalents

    * Total morphine equivalents for each post-operative day (POD) 0, 1, 2, 3...21+ * Total morphine equivalents for all post-operative days

    Time frame: post-operative days during hospital admission, up to 20 days

  2. Usage of PCA during hospitalization

    • Patient-controlled analgesia (PCA) use (collected mg per hour and morphine equivalent)

    Time frame: from admission to discharge, up to 20 days

  3. Opioid Consumption During Hospitalization

    * Use of intravenous (IV) narcotics (collected by "Yes" or "No") * Use of Narcan/Naloxon (collected by "Yes" or "No")

    Time frame: post-operative days during hospital admission, up to 20 days

  4. Opioid Refills After Surgery

    • Number of times opioid was refilled over 1 month

    Time frame: up to one month after surgery

  5. Opioid Prescribed After Surgery

    • Medications and number of pills prescribed at discharge

    Time frame: up to one month after surgery

  6. Opioid Refills (days) After Surgery

    • Number of days until 1st, 2nd, and 3rd refill

    Time frame: up to one month after surgery

  7. Opioids Left Over After Surgery

    • Number of pills leftover at one-month timepoint from surgery

    Time frame: up to one month after surgery

  8. Opioid Compliance During Hospitalization

    • Compliance with inpatient Enhanced Recovery After Surgery (ERAS) multimodal pain regimen

    Time frame: from admission to discharge, up to 20 days

  9. Pain Control Medication Usage

    Total usage of non-opioids medication was collected by mg with the following medications: * Acetaminophen * Dexamethasone * Lidocaine/ Lidoderm * Toradol * Valium * Flexeril * Gabapentin * Pregabalin * Ketamine

    Time frame: post-operative days during hospital admission, up to 20 days

  10. Pain Control Measurement

    Using the Visual Analogue Scale (VAS), patients had to rate their pain on a scale of 1 to 10, with 1 being the least pain and 10 being the least amount of pain. Timepoints included: * Preop pain score * Discharge pain score * Average pain score * Minimum pain score * Maximum pain score

    Time frame: from admission to discharge, up to 20 days

  11. Mobilization During Hospitalization

    * Collection of patient mobilization post-operative day (POD) 0, 1 * Collection of patient ambulation post-operative day (POD) 0, 1

    Time frame: post-operative days 0 and 1 during hospital admission

  12. Time to Mobilization During Hospitalization

    • Record time to mobilization and ambulation

    Time frame: post-operative days during hospital admission, up to 20 days

  13. Patient Falls

    • Collection of total number of inpatient falls

    Time frame: from admission to discharge, up to 20 days

  14. Usage of Foley During Hospitalization Course

    • Collection of patient use of Foley catheter post-operatively

    Time frame: from admission to discharge, up to 20 days

  15. Usage of Straight Catheterization During Hospitalization Course

    • Collection of patient use for straight catheterization post-operatively

    Time frame: from admission to discharge, up to 20 days

  16. Collection of Inpatient Status

    • Collection of patient hospitalization status post-operatively including: inpatient, outpatient and observational

    Time frame: from admission to discharge, up to 20 days

  17. Length of Stay (days)

    * Total length of stay (days) in hospital * Total length of stay (days) in intensive care unit (ICU)

    Time frame: from admission to discharge, up to 20 days

  18. Length of Stay (hours)

    * Total length of stay (hours) in hospital * Total length of stay (hours) in intensive care unit (ICU)

    Time frame: from admission to discharge, up to 20 days

  19. Collection of Patient Complications

    Collection of complications (Yes/No) including: * Death * Complications (including surgical site infection, urinary tract infections, cardiopulmonary events, wound dehiscence rates, and non-union rates, and others) * Morbidities

    Time frame: from admission to discharge, up to 20 days and up to 6 months after surgery

  20. Collection of Patient Re-admissions After Discharge

    * Collection of patient re-admission 30-days after surgery * Collection of patient re-admission 90-days after surgery

    Time frame: up to 3 months after surgery

  21. Collection of Re-operation After Surgery

    • Collection of any reoperations that occurred after the patient's initial surgery

    Time frame: up to 3 months after surgery

  22. Discharge Follow Up Questionnaire

    Measured with "Yes" or "No", patients were asked if they completed Enhanced Recovery After Surgery (ERAS) protocols and prior to surgery.

    Time frame: prior to surgery, up to 2-6 weeks after discharge from the hospital

  23. Collection of Discharge Disposition

    • Collection of discharge disposition following hospital discharge

    Time frame: from admission to discharge, up to 20 days

  24. Compliance During Hospitalization

    * Compliance with OR checklist * Compliance with inpatient ERAS wound care regimen

    Time frame: from admission to discharge, up to 20 days

  25. Patient Reported Outcomes EQ-5D

    Using the EQ-5D, data is collected on a scale of 1 to 3 with 1 being no problem, 2 being moderate problem and 3 being severe problem.

    Time frame: prior to surgery, up to 6 months after surgery

  26. Patient Reported Outcomes EQ-5D (health scale)

    Using the EQ-5D, data is collected health scale for today. On a scale 0 to 100 with 100 being the best health and 0 means the worst health.

    Time frame: prior to surgery, up to 6 months after surgery

  27. Patient Reported Outcomes Oswestry Low Back Pain Disability Questionnaire

    Using the oswestry low back pain disability index (ODI) scale, patients' responses are calculated on a scale of 0 to 100 with 0 being no pain and 100 being the worst pain.

    Time frame: prior to surgery, up to 6 months after surgery

  28. Patient Reported Outcomes Neck Disability Index

    Using the neck pain disability index (NDI) scale, patients' responses are calculated on a scale of 0 to 100 with 0 being no pain and 100 being the worst pain.

    Time frame: prior to surgery, up to 6 months after surgery

  29. Patient Reported Outcomes Neurosurgery Patient Satisfaction

    Using the Neurosurgery Patient Satisfaction Outcome questionnaire, patients' satisfaction are recorded with "Yes" or "No" to questions.

    Time frame: prior to surgery, up to 6 months after surgery

  30. Collection of Working Status

    Collection of patient working status including: * currently working * retired * disabled * not working due to a reason other than the condition being treated

    Time frame: prior to surgery, up to 6 months after surgery

  31. Consults

    • Rate of provider recommendation for additional consultations

    Time frame: Prior to surgery

  32. Enhanced Recovery at Penn (ERAP) Text Messaging Program - Patient Enrollment

    • Patient enrollment in service

    Time frame: Up to 3 months after surgery

  33. Enhanced Recovery at Penn (ERAP) Text Messaging Program - Compliance

    • ERAP compliance with carbohydrate loading and surgical site preparation

    Time frame: Up to 3 months after surgery

  34. Enhanced Recovery at Penn (ERAP) Text Messaging Program - Pain Score

    • Pain scores (1 to 10 with 1 being no pain and 10 being worst) at 1, 2, and 3 weeks and at 1, 2, and 3 months postop

    Time frame: Up to 3 months after surgery

  35. Enhanced Recovery at Penn (ERAP) Text Messaging Program - Pain Medication

    * Pain medication use at 1, 2, and 3 weeks and at 1, 2, and 3 months postop * Patient engagement and likelihood to recommend text messaging service

    Time frame: Up to 3 months after surgery

  36. Enhanced Recovery at Penn (ERAP) Text Messaging Program - Engagement

    • Patient engagement and likelihood to recommend text messaging service

    Time frame: Up to 3 months after surgery

07

Study locations

1 site
  • Hospital of the University of Pennsylvania
    Philadelphia, Pennsylvania 19102, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 26, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05830331
Lead sponsor
University of Pennsylvania
Responsible party
Zarina Ali (Chief, Penn Presbyterian Medical Center Department of Neurosurgery, University of Pennsylvania) — Principal investigator
First posted
Apr 26, 2023
Start date
Feb 18, 2019
Primary completion
Nov 13, 2020
Completion
Oct 13, 2021
Last update
Apr 26, 2023

Study contacts

Zarina Ali, MD
principal investigator · University of Pennsylvania
Neil Malhotra, MD
principal investigator · University of Pennsylvania

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion